# Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

> **NCT01216943** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 126 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution

## Key facts

- **NCT ID:** NCT01216943
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2013-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01216943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01216943, "Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01216943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*